GlassScriptPounce Xl Thrombectomy
Payments companies reported to CMS as associated with Pounce Xl Thrombectomy. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Pounce Xl Thrombectomy, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Pounce Xl Thrombectomy
These are the largest totals companies reported as associated with Pounce Xl Thrombectomy. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Gary Ansel | Columbus, OH | Interventional Cardiology | $150,248.35 |
| Lucas Ferrer Cardona | San Antonio, TX | Vascular Surgery | $19,830.33 |
| Nachiket Patel | Mesa, AZ | Interventional Cardiology | $16,135.09 |
| Kevin Onofrey | Detroit, MI | Vascular Surgery | $12,500.68 |
| Bruce Gray | Greenville, SC | Internal Medicine | $12,479.94 |
| Peter Monteleone | Kyle, TX | Interventional Cardiology | $6,750.00 |
| Dean Ferrera | East Chicago, IN | Interventional Cardiology | $5,324.59 |
| Christopher Leville | Saint Cloud, MN | Vascular Surgery | $3,800.00 |
| David O'Connor | Hackensack, NJ | Vascular Surgery | $545.77 |
| Michael Campbell | Lakeland, FL | Vascular & Interventional Radiology | $197.94 |
Prescribed Pounce Xl Thrombectomy?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.